Krsnaa Diagnostics Ltd

Krsnaa Diagnostics Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 06 Feb 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 27 April 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market standing.

Krsnaa Diagnostics Ltd, a small-cap player in the healthcare services sector, has experienced a notable shift in its technical momentum, moving from a mildly bearish to a bearish stance. Despite a recent downgrade in its Mojo Grade from Strong Sell to Sell, the stock’s price action and technical indicators reveal a complex picture of weakening momentum and cautious investor sentiment.

Krsnaa Diagnostics Ltd has witnessed a notable shift in its valuation parameters, moving from an attractive to a very attractive rating, signalling a potential inflection point for investors seeking value in the healthcare services sector. Despite recent share price softness, the company’s price-to-earnings (P/E) and price-to-book value (P/BV) ratios now present a compelling case when compared with both historical levels and peer benchmarks.

Krsnaa Diagnostics Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 06 Feb 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 16 April 2026, providing investors with the latest insights into its performance and outlook.

Krsnaa Diagnostics Ltd has witnessed a notable improvement in its valuation parameters, shifting from very attractive to attractive territory, despite a challenging market backdrop and subdued stock returns over the past year. This shift reflects a recalibration of investor sentiment and relative pricing compared to its healthcare services peers, offering a nuanced perspective on the company’s price attractiveness.

Krsnaa Diagnostics Ltd witnessed a robust start to trading on 8 April 2026, opening with a notable gap up of 7.08%, reflecting positive market sentiment despite a modest underperformance against the broader Sensex index for the day.

Krsnaa Diagnostics Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 06 February 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 05 April 2026, providing investors with an up-to-date view of the company’s performance and outlook.

The Sensex declined by 2.16% on 01 Apr 2026, while Krsnaa Diagnostics Ltd surged 7.18%, outperforming its Healthcare Services sector by 7.19 percentage points. This sharp single-session gain stands out as a stock-specific event amid a broadly weak market environment.

Krsnaa Diagnostics Ltd witnessed a sharp gap down at the opening of trade on 30 Mar 2026, reflecting heightened market apprehension. The stock opened with an 8.49% decline, hitting a new 52-week low of Rs.502.2, continuing its recent downward trajectory amid persistent volatility and sector underperformance.

A sharp decline in Krsnaa Diagnostics Ltd has pushed the stock to a fresh 52-week low of Rs 502.2 on 30 Mar 2026, marking a significant 7.63% drop over the last two sessions and underperforming its sector by nearly 2% today. This downturn comes amid a broader market weakness, with the Sensex itself trading close to its own 52-week low.

Krsnaa Diagnostics Ltd’s share price declined sharply on 27 Mar 2026, touching a new 52-week low of Rs.543.6. This marks a significant drop for the healthcare services company, reflecting ongoing pressures both within the stock and the wider market environment.

Krsnaa Diagnostics Ltd is rated Sell by MarketsMOJO, with this rating last updated on 06 February 2026. However, the analysis and financial metrics discussed here reflect the company’s current position as of 25 March 2026, providing investors with the latest insights into its performance and outlook.

For the fourth consecutive session, Krsnaa Diagnostics Ltd has closed lower, culminating in a fresh 52-week low of Rs 565.05 on 24 Mar 2026. This marks a 6.5% decline over the past four days, underscoring persistent selling pressure despite an intraday high of Rs 588.10 today.

For the third consecutive session, Krsnaa Diagnostics Ltd has declined, culminating in a fresh 52-week low of Rs 577 on 23 Mar 2026. This marks a 35.3% drop from its 52-week high of Rs 891.8, reflecting sustained selling pressure despite a sector that has also faced headwinds.

For the third consecutive session, Krsnaa Diagnostics Ltd has declined, culminating in a fresh 52-week low of Rs 577 on 23 Mar 2026. This drop comes despite some pockets of financial improvement, highlighting a complex interplay of factors weighing on the stock.

Krsnaa Diagnostics Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 06 February 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 14 March 2026, providing investors with the latest insights into its performance and outlook.

Krsnaa Diagnostics Ltd’s shares declined sharply to a fresh 52-week low of Rs.581 on 9 Mar 2026, marking a significant downturn amid broader market weakness and company-specific headwinds. The stock has underperformed its sector and benchmark indices, reflecting ongoing concerns about its recent financial performance and investor participation.